Compare RVSB & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVSB | NTRB |
|---|---|---|
| Founded | 1923 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.8M | 71.7M |
| IPO Year | 1993 | N/A |
| Metric | RVSB | NTRB |
|---|---|---|
| Price | $5.03 | $4.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 46.5K | 19.6K |
| Earning Date | 01-29-2026 | 12-11-2025 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | ★ 361.12 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $52,756,000.00 | $2,278,321.00 |
| Revenue This Year | $10.25 | $30.17 |
| Revenue Next Year | $11.23 | $3,394.36 |
| P/E Ratio | $22.87 | ★ N/A |
| Revenue Growth | ★ 15.20 | 12.69 |
| 52 Week Low | $4.74 | $3.72 |
| 52 Week High | $6.59 | $11.78 |
| Indicator | RVSB | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 45.40 |
| Support Level | $5.01 | $4.34 |
| Resistance Level | $5.62 | $4.77 |
| Average True Range (ATR) | 0.16 | 0.37 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 4.92 | 38.63 |
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.